Literature DB >> 2747644

Three breakpoints of variant t(2;8) translocations in Burkitt's lymphoma cells fall within a region 140 kilobases distal from c-myc.

B Henglein1, H Synovzik, P Groitl, G W Bornkamm, P Hartl, M Lipp.   

Abstract

The variant translocations t(2;8) in Burkitt's lymphoma cells join band q24 of chromosome 8, distal from c-myc, to the Igkappa locus, with considerable variation in the location of the breakpoints on chromosome 8. We report the cloning and molecular characterization of a chromosome 8 region, distal from the c-myc locus, which encompasses the breakpoints of the Burkitt's lymphoma cell lines BL64, BL21, and LY91 within 11 kilobase pairs, termed provisionally bvr-1 (Burkitt's variants' rearranging region 1). Using probes from the c-myc, the bvr-1, and the human pvt-1 loci obtained by chromosome walking coupled with pulsed-field gel electrophoresis, we have constructed a physical map of the region 3' of c-myc. We map bvr-1 and pvt-1 about 140 and 260 kilobase pairs, respectively, distal from c-myc.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2747644      PMCID: PMC363004          DOI: 10.1128/mcb.9.5.2105-2113.1989

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  31 in total

1.  Subgroup IV of human immunoglobulin K light chains is encoded by a single germline gene.

Authors:  H G Klobeck; G W Bornkamm; G Combriato; R Mocikat; H D Pohlenz; H G Zachau
Journal:  Nucleic Acids Res       Date:  1985-09-25       Impact factor: 16.971

2.  Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites.

Authors:  P N Cockerill; W T Garrard
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

3.  Possible role of immunoglobulin recombination sequences in the genesis of variant t(2;8) translocations of Burkitt lymphoma.

Authors:  M Lipp; P Hartl
Journal:  Curr Top Microbiol Immunol       Date:  1986       Impact factor: 4.291

4.  Separation of large DNA molecules by contour-clamped homogeneous electric fields.

Authors:  G Chu; D Vollrath; R W Davis
Journal:  Science       Date:  1986-12-19       Impact factor: 47.728

Review 5.  Molecular basis of human B cell neoplasia.

Authors:  C M Croce; P C Nowell
Journal:  Blood       Date:  1985-01       Impact factor: 22.113

6.  Supercoil sequencing: a fast and simple method for sequencing plasmid DNA.

Authors:  E Y Chen; P H Seeburg
Journal:  DNA       Date:  1985-04

7.  Proviral integration site Mis-1 in rat thymomas corresponds to the pvt-1 translocation breakpoint in murine plasmacytomas.

Authors:  L Villeneuve; E Rassart; P Jolicoeur; M Graham; J M Adams
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

8.  Analysis of the 3' flanking region of the human c-myc gene in lymphomas with the t(8;22) and t(2;8) chromosomal translocations.

Authors:  L K Sun; L C Showe; C M Croce
Journal:  Nucleic Acids Res       Date:  1986-05-27       Impact factor: 16.971

9.  Variant (6;15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the c-myc oncogene.

Authors:  S Cory; M Graham; E Webb; L Corcoran; J M Adams
Journal:  EMBO J       Date:  1985-03       Impact factor: 11.598

10.  c-myc and immunoglobulin kappa light chain constant genes are on the 8q+ chromosome of three Burkitt lymphoma lines with t(2;8) translocations.

Authors:  G A Rappold; H Hameister; T Cremer; S Adolph; B Henglein; U K Freese; G M Lenoire; G W Bornkamm
Journal:  EMBO J       Date:  1984-12-01       Impact factor: 11.598

View more
  28 in total

1.  The c-myc locus is a common integration site in type B retrovirus-induced T-cell lymphomas.

Authors:  L Rajan; D Broussard; M Lozano; C G Lee; C A Kozak; J P Dudley
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  In situ hybridization with fluoresceinated DNA.

Authors:  J Wiegant; T Ried; P M Nederlof; M van der Ploeg; H J Tanke; A K Raap
Journal:  Nucleic Acids Res       Date:  1991-06-25       Impact factor: 16.971

3.  An EcoRI RFLP downstream of the human c-myc gene.

Authors:  K Yamamoto; H F Lin; M Yamashita; N Miyoshi; A Tojo; M Shibuya
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

Review 4.  Mouse chromosome 15.

Authors:  B Mock; P E Neumann; J T Eppig; K Huppi
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

5.  Frequent amplification of c-myc in ground squirrel liver tumors associated with past or ongoing infection with a hepadnavirus.

Authors:  C Transy; G Fourel; W S Robinson; P Tiollais; P L Marion; M A Buendia
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

6.  Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26.

Authors:  K Morishita; E Parganas; C L William; M H Whittaker; H Drabkin; J Oval; R Taetle; M B Valentine; J N Ihle
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

7.  Effects of translocations on transcription from PVT.

Authors:  E Shtivelman; J M Bishop
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

8.  Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease.

Authors:  T Goossens; U Klein; R Küppers
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

9.  Retroviral insertions 90 kilobases proximal to the Evi-1 myeloid transforming gene activate transcription from the normal promoter.

Authors:  C Bartholomew; J N Ihle
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

10.  Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations.

Authors:  G Nucifora; C R Begy; H Kobayashi; D Roulston; D Claxton; J Pedersen-Bjergaard; E Parganas; J N Ihle; J D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.